Latest Balance Sheet News

Nutritional Growth Solutions Ltd (NGS) has had its trading suspension lifted following a key announcement about a capital raising, signaling renewed market activity.

Brightstar Resources has unveiled a robust multi-hub expansion strategy in Western Australia, boosted by its strategic acquisition of Aurumin Limited. The company targets a significant production increase to 200,000 ounces of gold annually by 2029.

Silver Mines Limited has raised $33 million through a $30 million placement and a $3 million share purchase plan, bolstering its development and exploration ambitions in Australia and the US.

Aeris Resources has outlined its FY26 production targets, aiming for a 40-49kt copper equivalent output while advancing key projects and planning asset divestments to strengthen its balance sheet.

Trajan Group Holdings has reported record FY25 revenue of $166.5 million, exceeding guidance despite operational headwinds. However, EBITDA fell slightly short of forecasts, reflecting challenges in supply chains and market shifts.

HeraMED Limited has resumed trading on the ASX following the release of its quarterly reports and a significant capital raising announcement, marking a pivotal moment for the medical device company.

Hot Chili Limited has announced a non-renounceable entitlement offer aiming to raise approximately A$14 million to advance its strategic partnering efforts and drilling programs. Eligible shareholders can subscribe for new shares at 60 cents each, with funds earmarked for exploration and corporate purposes.

FireFly Metals has secured environmental approval and reported exceptional metallurgical results for its Green Bay Copper-Gold Project in Canada, setting the stage for a production restart. With economic studies underway and strong funding, the project is rapidly advancing toward a scoping study release in early 2026.

Vitrafy Life Sciences reported strong FY25 progress with 75% sales growth, advanced cryopreservation technology development, and a robust cash position. The company outlines a clear commercialisation roadmap for FY26, including product launches and expanded U.S. operations.

Vitrafy Life Sciences reported a $32.7 million loss for FY25, driven by investments in its next-generation cryopreservation platform following a $35 million IPO and a $4.8 million government grant. The company is progressing commercialization efforts with key partnerships in human and animal health.

TPG Telecom has completed its transformative Vocus acquisition, launching a $4.7 billion capital management plan that includes a $3 billion shareholder return, significant debt repayment, and strong FY25 financial guidance.

Credit Corp Group Limited reported a robust 14.6% revenue increase and an 85.6% jump in profit after tax for the year ended June 2025, alongside a significant dividend hike.